Voyager Therapeutics
VYGR
VYGR
110 hedge funds and large institutions have $211M invested in Voyager Therapeutics in 2023 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 35 increasing their positions, 33 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
31% less capital invested
Capital invested by funds: $308M → $211M (-$96.5M)
51% less call options, than puts
Call options by funds: $368K | Put options by funds: $748K
Holders
110
Holding in Top 10
–
Calls
$368K
Puts
$748K
Top Buyers
1 | +$4.29M | |
2 | +$3.45M | |
3 | +$1.65M | |
4 |
AQR Capital Management
Greenwich,
Connecticut
|
+$1.54M |
5 |
GC
Globeflex Capital
San Diego,
California
|
+$982K |
Top Sellers
1 | -$3.79M | |
2 | -$2.49M | |
3 | -$2.15M | |
4 |
![]()
Marshall Wace
London,
United Kingdom
|
-$2.02M |
5 |
Citadel Advisors
Miami,
Florida
|
-$1.49M |